Work

How do I: Evaluate the safety and legitimacy of unproven cellular therapies?

Year: 2022

Type: article

Source: Transfusion

DOI: 10.1111/trf.16814

Authors: Indira Guleria, Maria de Los Angeles Muñiz, Matthew Wilgo, Asawari Bapat, Wanxing Cui, Yen‐Michael Sheng Hsu, Madhan Jeyaraman, Sathish Muthu, Federico Rodriguez, Andrew Fesnak, Christina Celluzzi, Deborah Sesok‐Pizzini, Ronit Reich‐Slotky, Thomas Spitzer

Institutions: Brigham and Women's Hospital, Harvard University, Weill Cornell Medicine, Georgetown University, Georgetown University Medical Center, MedStar Georgetown University Hospital, University of Pittsburgh, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Dr. M.G.R. Educational and Research Institute, Tamil Nadu Dr. M.G.R. Medical University, Sharda University, Government Medical College and Hospital, UF Health Shands Hospital, University of Florida Health, UF Health Cancer Center, University of Pennsylvania, Hackensack University Medical Center, Massachusetts General Hospital

Language: English

Topic: Biomedical Ethics and Regulation

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4211005307

FWCI: 1.028

Cites: 22

Cited by: 9

Related to: 10